SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001562180-23-008273
Filing Date
2023-12-11
Accepted
2023-12-11 16:15:33
Documents
1
Period of Report
2023-12-04

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4/A  
1 PRIMARY DOCUMENT primarydocument.xml 4/A 9075
  Complete submission text file 0001562180-23-008273.txt   10698
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Issuer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3826 Laboratory Analytical Instruments

Mailing Address C/O EYEPOINT PHARMACEUTICALS, INC. 480 PLEASANT STREET, SUITE A-210 WATERTOWN MA 02472
Business Address
Pine Michael Craig (Reporting) CIK: 0001904458 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-51122 | Film No.: 231478310